News Feed Opinion Career Insight Dialogues Blog
Positive Societies Drugs Stories History
December, 2023
December 2023
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Ani Haykuni: My story isn’t about sadness or fear
Photo from Ani Haykun/LinkedIn
Oct 21, 2023, 16:08

Ani Haykuni: My story isn’t about sadness or fear

Ani Haykuni, Founder and CEO of Vann, shared on LinkedIn:

“October is the breast cancer awareness month, and you probably know that I have lived through cancer twice, but don’t be scared. My story isn’t about sadness or fear regardless of the numerous things that I have been through so far. There has never been negativity, anger, or disappointment since the first day of my diagnosis. I have never asked “why me and not others’’, “what have I done to deserve the illness?” I have always been confident that things happen in our lives for a reason to help us shape the direction we are on.

My story has always been about belief, hope, love, support, light, new dreams, dedication and commitment. It has been about not giving up. Many years ago, I was reborn, and my passion for making a difference in the world and for finding the meaning of my life, my goals, the support of my family, my friends and the thousands of people from around the world has helped me transform my life into something even better and convert my experience with cancer into something beautiful and positive. The world that I want to create for all of us there is only trust, support, kindness and happiness. This is the world that I want to live in. This is what I believe in. This is what my work has been aimed at for a very long time, and that is why I have founded Vann, so that we create a safer future for all people affected by cancer and help find answers about this disease.

Stay well people!

Drop me a message if you share these values too or you would like to be part of the cause.
Sincerely yours,
Ani.”

Source: Ani Haykuni/LinkedIn.

Ani Haykuni Breast Cancer cancer OncoDaily Oncology Vann
Insight
Dec 9, 2023, 04:44
President Biden: It's good for the millions of Americans who can't afford their medications
Blog
Dec 9, 2023, 00:38
Thomas Hofmarcher: This is what a great panel discussion looks like!
Blog
Dec 9, 2023, 00:32
Zhiheng Xu: It's not just about how much statistics you know
Blog
Dec 9, 2023, 00:23
Priscilla Chan: Mark and I wrote our annual letter this year about how some of our earliest bets in science are letting us take advantage of this moment in AI
Blog
Dec 9, 2023, 00:18
David Fajgenbaum: 1 in 10 of us will develop a disease with no treatments
Career
Dec 8, 2023, 17:54
Dana-Farber News congratulates Sara Tolaney on receiving the Susan G. Komen 2023 Rising Star Researcher Award
Drugs
Dec 8, 2023, 17:50
Pure Biologics to test molecule PBA-0405 in project PB004 in a Phase 0 clinical trial in patients with solid tumors - The Antibody Society
Drugs
Dec 8, 2023, 17:46
Earle Burgess: Interested in new treatments being developed for advanced (urothelial) bladder cancer?
Insight
Dec 8, 2023, 17:40
Ibrahim Halil Sahin: A common question I received after my tweet on the PEGASUS trial...
Career
Dec 8, 2023, 17:35
Timothy M. Pawlik: Excited to announce Samilia Obeng-Gyasi as THE inaugural Endowed Surgical Professor in Health Equity
Insight
Dec 8, 2023, 17:32
Daniel Stover: Tumor genomic testing (TGT) is standard for MBC patients
Blog
Dec 8, 2023, 17:27
Tedros Adhanom Ghebreyesus: Gaza cannot afford to lose any more hospitals…
Insight
Positive
Societies
Career